Walter Stummer

Walter Stummer's AcademicInfluence.com Rankings

Walter Stummer

Physics

#6893

World Rank

#8883

Historical Rank

physics Degrees

Download Badge

Physics

Walter Stummer's Degrees

Bachelors Physics University of Vienna
Masters Physics University of Vienna

Why Is Walter Stummer Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Walter Stummer's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. (2006) (2773)
Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. (2000) (850)
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME: IDENTIFICATION OF AND ADJUSTMENT FOR BIAS (2008) (836)
Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. (1998) (642)
Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. (2008) (321)
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial (2019) (275)
Comparison of 18F-FET PET and 5-ALA fluorescence in cerebral gliomas (2011) (269)
Influence of cranioplasty on postural blood flow regulation, cerebrovascular reserve capacity, and cerebral glucose metabolism. (2000) (265)
Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article. (2011) (245)
Technical Principles for Protoporphyrin-IX-Fluorescence Guided Microsurgical Resection of Malignant Glioma Tissue (1998) (242)
Early fatal hemorrhage after endovascular cerebral aneurysm treatment with a flow diverter (SILK-Stent) (2010) (228)
5-Aminolevulinic Acid-derived Tumor Fluorescence: The Diagnostic Accuracy of Visible Fluorescence Qualities as Corroborated by Spectrometry and Histology and Postoperative Imaging (2013) (228)
What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas? (2015) (218)
In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. (1998) (213)
Reduced Mortality and Brain Damage After Locomotor Activity in Gerbil Forebrain Ischemia (1994) (212)
Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients (2009) (185)
Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. (2005) (183)
Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion (2011) (176)
Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5‐aminolevulinic acid induced protoporphyrin IX (2007) (175)
Fluorescence-guided resection of malignant gliomas using 5-aminolevulinic acid: practical use, risks, and pitfalls. (2008) (161)
Finding the anaplastic focus in diffuse gliomas: The value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence (2011) (155)
5-ALA and FDA approval for glioma surgery (2019) (152)
ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment. (2007) (151)
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial. (2016) (140)
Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival (2011) (139)
Fluorescence-guided resections of malignant gliomas--an overview. (2003) (132)
5‐ALA in the management of malignant glioma (2018) (131)
18F-FET PET differentiation of ring-enhancing brain lesions. (2006) (130)
Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery (2012) (127)
Transport of 5-aminolevulinic acid between blood and brain (2003) (127)
Long-sustaining response in a patient with non-resectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-ALA: case report (2008) (124)
CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients. (2016) (120)
Mechanisms of 5‐Aminolevulinic Acid Uptake at the Choroid Plexus (2000) (115)
The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, 18F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor Molecular Factors (2015) (112)
Efficacy of gamma knife radiosurgery for nonfunctioning pituitary adenomas: a quantitative follow up with magnetic resonance imaging-based volumetric analysis. (2002) (108)
Mechanisms of tumor-related brain edema. (2007) (104)
Microscope-Integrated Quantitative Analysis of Intraoperative Indocyanine Green Fluorescence Angiography for Blood Flow Assessment: First Experience in 30 Patients (2012) (96)
Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid. (2002) (89)
The importance of surgical resection in malignant glioma (2009) (89)
Predicting the “usefulness” of 5-ALA-derived tumor fluorescence for fluorescence-guided resections in pediatric brain tumors: a European survey (2014) (83)
Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients (2018) (81)
Randomized, Prospective Double-Blinded Study Comparing 3 Different Doses of 5-Aminolevulinic Acid for Fluorescence-Guided Resections of Malignant Gliomas (2017) (78)
The use of local agents: Surgicel and Surgifoam. (2005) (78)
The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value? (2017) (75)
Kinetics of Photofrin II in perifocal brain edema. (1993) (74)
Favorable outcome in the elderly cohort treated by concomitant temozolomide radiochemotherapy in a multicentric phase II safety study of 5-ALA (2011) (74)
Terson's syndrome in subarachnoid hemorrhage and severe brain injury accompanied by acutely raised intracranial pressure. (2001) (70)
BRAF‐KIAA1549 fusion transcripts are less frequent in pilocytic astrocytomas diagnosed in adults (2011) (70)
Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro (2011) (68)
DENDRITIC CELL VACCINATION IN PATIENTS WITH MALIGNANT GLIOMAS: CURRENT STATUS AND FUTURE DIRECTIONS (2006) (68)
Thalamic Astrocytomas: Surgical Anatomy and Results of a Pilot Series Using Maximum Microsurgical Removal (2000) (68)
Brain Invasion in Meningiomas: Incidence and Correlations with Clinical Variables and Prognosis. (2016) (67)
Fluorescence in neurosurgery: Its diagnostic and therapeutic use. Review of the literature. (2015) (57)
Simultaneous fluorescein sodium and 5-ALA in fluorescence-guided glioma surgery (2015) (56)
Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society (2017) (56)
Cerebral protection against ischemia by locomotor activity in gerbils. Underlying mechanisms. (1995) (55)
Haemostasis in spine surgery. The use of local agents: Surgicel and Surgifoam (2004) (54)
Surgery for meningioma in the elderly and long-term survival: comparison with an age- and sex-matched general population and with younger patients. (2017) (53)
Factors predicting recurrence of chronic subdural haematoma: the influence of intraoperative irrigation and low-molecular-weight heparin thromboprophylaxis (2012) (53)
Fluorescence Imaging/Agents in Tumor Resection. (2017) (53)
Custom-tailored transdural anterior transpetrosal approach to ventral pons and retroclival regions. (2006) (52)
Inducible nitric oxide synthase: a possible key factor in the pathogenesis of chronic vasospasm after experimental subarachnoid hemorrhage. (1999) (51)
Gamma Knife radiosurgery following subtotal resection of vestibular schwannoma (2014) (51)
Dependence of subarachnoid hemorrhage on climate conditions: a systematic meteorological analysis from the dusseldorf metropolitan area. (2008) (51)
Modulation of migratory activity and invasiveness of human glioma spheroids following 5-aminolevulinic acid-based photodynamic treatment. Laboratory investigation. (2011) (50)
Diffuse Astrocytoma, IDH-Wildtype: A Dissolving Diagnosis (2018) (49)
Terson's syndrome in subarachnoid hemorrhage and severe brain injury accompanied by acutely raised intracranial pressure (1998) (49)
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07) (2018) (49)
When the Infection Hits the Wound: Matched Case-Control Study in a Neurosurgical Patient Collective Including Systematic Literature Review and Risk Factors Analysis. (2016) (47)
Is Visible Aminolevulinic Acid-Induced Fluorescence an Independent Biomarker for Prognosis in Histologically Confirmed (World Health Organization 2016) Low-Grade Gliomas? (2018) (47)
Established and emerging uses of 5-ALA in the brain: an overview (2019) (47)
The influence of cranioplasty on postural blood flow regulation, cerebrovascular reserve capacity, and cerebral glucose metabolism. (2000) (46)
Leukocyte-Endothelium Interactions in Pial Venules during the Early and Late Reperfusion Period after Global Cerebral Ischemia in Gerbils (2000) (45)
Combination of ALA-induced fluorescence-guided resection and intraoperative open photodynamic therapy for recurrent glioblastoma: case series on a promising dual strategy for local tumor control. (2020) (44)
Brain invasion and the risk of seizures in patients with meningioma. (2019) (44)
Dual-labeling with 5-aminolevulinic acid and fluorescein for fluorescence-guided resection of high-grade gliomas: technical note. (2017) (43)
Transorbital Keyhole Approach to Anterior Communicating Artery Aneurysms (2001) (43)
FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma (2018) (43)
Prediction of brain invasion in patients with meningiomas using preoperative magnetic resonance imaging (2018) (42)
Maximizing safe resections: the roles of 5-aminolevulinic acid and intraoperative MR imaging in glioma surgery—review of the literature (2017) (41)
Spreading depression triggers ictaform activity in partially disinhibited neuronal tissues (2014) (40)
EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma. (2019) (39)
Cordectomy as final treatment option for diffuse intramedullary malignant glioma using 5-ALA fluorescence-guided resection (2010) (39)
Evidence for peroxidative damage by nitric oxide in experimental chronic cerebral vasospasm. (1996) (38)
5-ALA fluorescence–guided surgery in pediatric brain tumors—a systematic review (2019) (37)
CD4(+) T cells predominate in cerebrospinal fluid and leptomeningeal and parenchymal infiltrates in cerebral amyloid β-related angiitis. (2012) (37)
Human Neural Stem/Progenitor Cells Derived From Epileptic Human Brain in a Self-Assembling Peptide Nanoscaffold Improve Traumatic Brain Injury in Rats (2018) (37)
Extent of Resection and Survival in Glioblastoma Multiforme. (2009) (36)
Management of patients with severe head injury in the preclinical phase: a prospective analysis. (1997) (36)
A Pilot Cost-Effectiveness Analysis of Treatments in Newly Diagnosed High-Grade Gliomas: The Example of 5-Aminolevulinic Acid Compared With White-Light Surgery (2015) (36)
Anatomic features of glioblastoma and their potential impact on survival (2015) (35)
Oedema formation in experimental photo-irradiation therapy of brain tumours using 5-ALA (2004) (35)
Bevacizumab, irinotecan, and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-nonmethylated glioblastoma patients: First results from the randomized multicenter GLARIUS trial. (2013) (34)
Conscious sedation with dexmedetomidine compared with asleep-awake-asleep craniotomies in glioma surgery: an analysis of 180 patients. (2018) (34)
The transorbital keyhole approach: early and long-term outcome analysis of approach-related morbidity and cosmetic results. Technical note. (2011) (33)
Blood-Brain Barrier Glutamine Transport during Normoglycemic and Hyperglycemic Focal Cerebral Ischemia (1999) (32)
Photodynamic therapy within edematous brain tissue: considerations on sensitizer dose and time point of laser irradiation. (1996) (32)
Clinical determination of tissue optical properties in vivo by spatially resolved reflectance measurements (2003) (31)
Review of clinical trials in intraoperative molecular imaging during cancer surgery (2019) (31)
Interstitial Photodynamic Therapy of Brain Tumors (2010) (29)
Sequential changes in neuronal activity in single neocortical neurons after spreading depression (2012) (29)
5-Aminolevulinic Acid Fluorescence-Guided Resection of 18F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma (2019) (29)
Estradiol stimulates vascular endothelial growth factor and interleukin-6 in human lactotroph and lactosomatotroph pituitary adenomas. (2004) (29)
Human CCR5high effector memory cells perform CNS parenchymal immune surveillance via GZMK-mediated transendothelial diapedesis. (2019) (29)
Temporary Aneurysm Orifice Balloon Occlusion as an Alternative to Retrograde Suction Decompression for Giant Paraclinoid Internal Carotid Artery Aneurysms: Technical Note (2005) (28)
5-Aminolevulinic Acid and the Blood-Brain Barrier – A Review (2003) (28)
Symptomatic intracystic hemorrhage in pineal cysts. Report of 3 cases. (2009) (28)
ADAMTS genes and the risk of cerebral aneurysm. (2016) (27)
ALA-induced porphyrin accumulation in medulloblastoma and its use for fluorescence-guided surgery. (2011) (27)
The value of metabolic imaging in diagnosis and resection of cerebral gliomas (2005) (27)
Cerebral lactate production in relation to intracranial pressure, cranial computed tomography findings, and outcome in patients with severe head injury (2005) (26)
Usefulness of 5-ALA (Gliolan®)-derived PPX fluorescence for demonstrating the extent of infiltration in atypical meningiomas (2014) (26)
TSPO imaging-guided characterization of the immunosuppressive myeloid tumor microenvironment in patients with malignant glioma. (2020) (26)
Fluorescence-Based Measurement of Real-Time Kinetics of Protoporphyrin IX After 5-Aminolevulinic Acid Administration in Human In Situ Malignant Gliomas. (2019) (26)
Expression of vascular endothelial growth factor (VEGF) and its receptors VEGFR1 and VEGFR2 in primary and recurrent WHO grade III meningiomas. (2013) (26)
Aminolevulinic Acid-Mediated Photodynamic Therapy of Human Meningioma: An in Vitro Study on Primary Cell Lines (2015) (26)
Functional in vitro studies on the role and regulation of interleukin-6 in human somatotroph pituitary adenomas. (2003) (26)
Supramarginal resection of glioblastoma: 5-ALA fluorescence, combined intraoperative strategies and correlation with survival. (2019) (26)
Fluorescence-guided surgery with aminolevulinic acid for low-grade gliomas (2018) (25)
The effects of hypo- and hyperkalemia on choroid plexus potassium transport (1997) (25)
First experience in 5-ALA fluorescence-guided and endoscopically assisted microsurgery of brain tumors (2008) (25)
ACTR-58. PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial (2017) (25)
Management of patients with low-grade gliomas - a survey among German neurosurgical departments. (2011) (25)
Acute morphological sequelae of photodynamic therapy with 5-aminolevulinic acid in the C6 spheroid model (2007) (25)
5-Aminolaevulinic Acid-Induced Fluorescence in Primary Central Nervous System Lymphoma. (2017) (25)
Blood—Brain Barrier Taurine Transport during Osmotic Stress and in Focal Cerebral Ischemia (1995) (24)
Dynamic ICG Fluorescence Provides Better Intraoperative Understanding of Arteriovenous Fistulae (2013) (23)
Supratentorial meningeal melanocytoma mimicking a convexity meningioma (2006) (23)
The evolution of cranial meningioma surgery—a single-center 25-year experience (2018) (23)
Fluorescein in brain metastasis and glioma surgery (2015) (22)
Kinetics of porphyrin fluorescence accumulation in pediatric brain tumor cells incubated in 5-aminolevulinic acid (2014) (22)
Prediction of high-grade histology and recurrence in meningiomas using routine preoperative magnetic resonance imaging - A systematic review. (2019) (22)
Telomerase activity, TERT expression, hTERT promoter alterations, and alternative lengthening of the telomeres (ALT) in meningiomas – a systematic review (2019) (21)
Adverse events in brain tumor surgery: incidence, type, and impact on current quality metrics (2019) (21)
hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas (2016) (21)
Mechanisms of Brain Ion Homeostasis during Acute and Chronic Variations of Plasma Potassium (1995) (21)
Can systematic analysis of morbidity and mortality reduce complication rates in neurosurgery? (2010) (21)
Myopericytoma: A Series of 5 Cases Affecting the Nervous System. (2015) (20)
Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study. (2016) (20)
Quality Indicators in Cranial Neurosurgery: Which Are Presently Substantiated? A Systematic Review. (2017) (20)
Poor man’s fluorescence? (2015) (20)
Inducible nitric oxide synthase: a possible key factor in the pathogenesis of chronic vasospasm after experimental subarachnoid hemorrhage (1999) (20)
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1 (2020) (20)
Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial. (2019) (19)
Intraoperative fluorescence diagnosis in the brain: a systematic review and suggestions for future standards on reporting diagnostic accuracy and clinical utility (2019) (19)
Multimodal Imaging of Patients With Gliomas Confirms 11C-MET PET as a Complementary Marker to MRI for Noninvasive Tumor Grading and Intraindividual Follow-Up After Therapy (2017) (19)
Cell injury and receptor expression in the epileptic human amygdala (2019) (18)
Fluorescence Detection of Human Malignancies Using Incoherent Light Systems (2003) (18)
In-Vitro Use of 5-ALA for Photodynamic Therapy in Pediatric Brain Tumors (2018) (18)
Experimental Research Photodynamic Effects in Perifocal, Oedematous Brain Tissue (2002) (18)
Cerebrospinal fluid leakage in Gorham-Stout disease due to dura mater involvement after progression of an osteolytic lesion in the thoracic spine. (2014) (17)
Clinical, radiological, and histopathological predictors for long-term prognosis after surgery for atypical meningiomas (2019) (17)
Factors confounding fluorescein-guided malignant glioma resections: edema bulk flow, dose, timing, and now: imaging hardware? (2015) (17)
hTERT promoter methylation in pituitary adenomas (2015) (17)
Where and When to Cut? Fluorescein Guidance for Brain Stem and Spinal Cord Tumor Surgery—Technical Note (2017) (17)
The effects of tetanic stimulation on plasticity of remote synapses in the hippocampus‐perirhinal cortex‐amygdala network (2012) (17)
Brain Invasion in Meningiomas: The Rising Importance of a Uniform Neuropathologic Assessment After the Release of the 2016 World Health Organization Classification of Central Nervous System Tumors. (2016) (16)
5-ALA fluorescence-guided surgery of CNS tumors (2019) (15)
Fluorescence Guidance and Intraoperative Adjuvants to Maximize Extent of Resection. (2020) (15)
Surgical Adjuncts to Increase the Extent of Resection: Intraoperative MRI, Fluorescence, and Raman Histology. (2019) (15)
Aquaporin-4 in glioma and metastatic tissues harboring 5-aminolevulinic acid-induced porphyrin fluorescence (2013) (15)
Rubidium entry into brain and cerebrospinal fluid during acute and chronic alterations in plasma potassium. (1994) (14)
Surgical treatment in a patient with Klippel–Feil syndrome and anterior cervical meningomyelocele: a case report and review of literature (2013) (14)
Cerebral perfusion changes in chronic subdural hematoma. (2013) (14)
Spinal meningiomas – Risks and potential of an increasing age at the time of surgery (2018) (14)
Glioma Tissue Obtained by Modern Ultrasonic Aspiration with a Simple Sterile Suction Trap for Primary Cell Culture and Pathological Evaluation (2014) (13)
O10.04THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS: FINAL SURVIVAL RESULTS AND QUALITY OF LIFE (2014) (13)
Is the Simpson Grading System Applicable to Estimate the Risk of Tumor Progression After Microsurgery for Recurrent Intracranial Meningioma? (2018) (13)
Preoperative Localization of Spinal and Peripheral Pathologies for Surgery by Computed Tomography–Guided Placement of a Specialized Needle System (2010) (13)
Fluorescence-guided resections and photodynamic therapy for malignant gliomas using 5-aminolevulinic acid (2005) (13)
Establishing risk-adjusted quality indicators in surgery using administrative data—an example from neurosurgery (2019) (13)
A comparative analysis of MAPK pathway hallmark alterations in pilocytic astrocytomas: age‐related and mutually exclusive (2015) (13)
Risk of tumor recurrence in intracranial meningiomas: comparative analyses of the predictive value of the postoperative tumor volume and the Simpson classification. (2020) (13)
The Simpson grading: defining the optimal threshold for gross total resection in meningioma surgery (2020) (12)
5-ALA Fluorescence in Native Pituitary Adenoma Cell Lines: Resection Control and Basis for Photodynamic Therapy (PDT)? (2016) (12)
Survival and quality of life in the randomized, multicenter GLARIUS trial investigating bevacizumab/irinotecan versus standard temozolomide in newly diagnosed, MGMT-non-methylated glioblastoma patients. (2014) (12)
Dual labeling with 5-aminolevulinic acid and fluorescein in high-grade glioma surgery with a prototype filter system built into a neurosurgical microscope: technical note. (2020) (11)
Activation of leukocyte–endothelial interactions and reduction of selective neuronal death after global cerebral ischemia (2007) (11)
Brain invasion in meningiomas: does surgical sampling impact specimen characteristics and histology? (2019) (11)
Long-term survival following additive radiotherapy in patients with atypical teratoid rhabdoid tumors (2016) (11)
Validating a new generation filter system for visualizing 5-ALA-induced PpIX fluorescence in malignant glioma surgery: a proof of principle study (2020) (11)
Altered inhibition in the hippocampal neural networks after spreading depression (2015) (11)
MGMT promoter methylation status in anaplastic meningiomas (2010) (11)
Regression of Pineal Lesions: Spontaneous or Iatrogenic? A Case Report and Systematic Literature Review. (2017) (10)
Infrared Thermography in Surgery of Newly Diagnosed Glioblastoma Multiforme: A Technical Case Report (2017) (10)
Impact of distress screening algorithm for psycho-oncological needs in neurosurgical patients (2018) (10)
Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma (2018) (10)
Markers for Identifying and Targeting Glioblastoma Cells during Surgery (2019) (10)
TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma (2021) (10)
Quality of Life in Brain Tumor Patients and Their Relatives Heavily Depends on Social Support Factors during the COVID-19 Pandemic (2021) (10)
Complementary Molecular and Elemental Mass-Spectrometric Imaging of Human Brain Tumors Resected by Fluorescence-Guided Surgery. (2018) (10)
Initial experience with [18F]DPA-714 TSPO-PET to image inflammation in primary angiitis of the central nervous system (2020) (10)
The fear of 5-ALA--is it warranted? (2014) (10)
The Use of 5-Aminolevulinic Acid in Low-Grade Glioma Resection: A Systematic Review. (2019) (9)
Prospective documentation and analysis of the pre- and early clinical management in severe head injury in southern Bavaria at a population based level. (2004) (9)
Intracavitary radioimmunotherapy of high-grade gliomas: present status and future developments (2019) (9)
Visualizing protoporphyrin IX formation in the dura tail of meningiomas by mass spectrometry imaging (2018) (9)
Leukocyte-endothelium interactions in global cerebral ischemia. (1997) (9)
Fluorescein for vascular and oncological neurosurgery (2013) (9)
δ-Aminolevulinic acid-induced fluorescence-guided resection of brain tumors. (2015) (8)
The rise of quality indicators in neurosurgery: 30-day unplanned reoperation rate evaluated in 3760 patients—a single-center experience (2019) (8)
Response to journal club: 5-aminolevulinic acid-derived tumor fluorescence: the diagnostic accuracy of visible fluorescence qualities as corroborated by spectrometry and histology and postoperative imaging. (2015) (8)
Fluorescence-Guided Resection of Spinal Metastases of Malignant Glioma – Report of 2 Cases (2011) (8)
High-Intensity Physical Exercise in a Glioblastoma Patient under Multimodal Treatment. (2019) (8)
Clinical vasospasm after an extended endoscopic assisted approach for recurrent pituitary adenoma. Illustrative case and systematic review of the literature. (2019) (8)
Predicting the risk of postoperative recurrence and high-grade histology in patients with intracranial meningiomas using routine preoperative MRI (2020) (8)
Endoscopic management of a low-grade thalamic glioma: a safe alternative to open microsurgery? (2017) (8)
Real-time in vivo kinetics of protoporphyrin IX after administration of 5-aminolevulinic acid in meningiomas and comparative analyses with glioblastomas (2020) (8)
Local Tumor Control and Clinical Symptoms After Gamma Knife Radiosurgery for Residual and Recurrent Vestibular Schwannomas. (2019) (8)
O-11-172 Intraoperative detection of malignant glioma by 5-ALA induced protoporphyrin IX fluorescence (1997) (7)
Malignant progression of a histone H3.3 K27M-mutated spinal pilocytic astrocytoma in an adult. (2017) (7)
Diagnostic accuracy of different clinical screening criteria for blunt cerebrovascular injuries compared with liberal state of the art computed tomography angiography in major trauma (2020) (7)
Spectroscopic measurement of 5-ALA-induced intracellular protoporphyrin IX in pediatric brain tumors (2019) (7)
Simpson grade IV resections of skull base meningiomas: does the postoperative tumor volume impact progression? (2018) (7)
Commentary: Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation. (2016) (7)
Ependymal fluorescence in fluorescence-guided resection of malignant glioma: a systematic review (2019) (7)
5-Aminolevulinic Acid-Induced Porphyrin Contents in Various Brain Tumors: Implications Regarding Imaging Device Design and Their Validation (2021) (7)
ALA-mediated fluorescence-guided resection (FGR) and PDT of glioma (2009) (7)
Improvement of Rat Spinal Cord Injury Following Lentiviral Vector-Transduced Neural Stem/Progenitor Cells Derived from Human Epileptic Brain Tissue Transplantation with a Self-assembling Peptide Scaffold (2021) (7)
The 30-day readmission rate in neurosurgery—a useful indicator for quality assessment? (2020) (7)
Second-look strokectomy of cerebral infarction areas in patients with severe herniation. (2019) (7)
Teaching the concept of brain death in undergraduate medical education. (2015) (6)
Response assessment of somatostatin receptor targeted radioligand therapies for progressive intracranial meningioma (2020) (6)
Risk-assessment in chronic subdural hematoma evaluated in 148 patients - A score for predicting recurrence (2020) (6)
Somatostatin receptor targeted radioligand therapy in head and neck paraganglioma. (2020) (6)
Recombinant Factor VIIa for the Prophylaxis of Perioperative Hemorrhage in a Patient With Congenital Factor XI Deficiency Undergoing Brain Tumor Neurosurgery (2008) (6)
Cerebellar Anaplastic Astrocytoma in an Adult with Neurofibromatosis Type 1: Case Report and Review of Literature (2013) (6)
Routine postoperative CT-scans after burr hole trepanation for chronic subdural hematoma - better before or after drainage removal? (2013) (6)
Antitumor Effects of 5-Aminolevulinic Acid on Human Malignant Glioblastoma Cells (2021) (6)
5-ALA kinetics in meningiomas: analysis of tumor fluorescence and PpIX metabolism in vitro and comparative analyses with high-grade gliomas (2021) (6)
Development and validation of a triple-LED surgical loupe device for fluorescence-guided resections with 5-ALA. (2021) (5)
Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas (2022) (5)
RTHP-22. INFLAMMATORY RESPONSE AFTER MODIFIED NANOTHERM AND RADIOTHERAPY OF RECURRENT GLIOBLASTOMA (2016) (5)
Spreading Depolarization Facilitates the Transition of Neuronal Burst Firing from Interictal to Ictal State (2020) (5)
Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications. (2011) (5)
Characterization of autofluorescence and quantitative protoporphyrin IX biomarkers for optical spectroscopy-guided glioma surgery (2021) (5)
Initial psycho-oncological counselling in neuro-oncology: analysis of topics and needs of brain tumour patients (2018) (5)
Development and validation of prediction scores for nosocomial infections, reoperations, and adverse events in the daily clinical setting of neurosurgical patients with cerebral and spinal tumors. (2020) (5)
Letter: Retention of ATRX and DAXX Expression in Meningiomas. (2017) (5)
Letter to the Editor. Brain invasion and the risk for postoperative hemorrhage and neurological deterioration after meningioma surgery. (2018) (5)
Letter: Brain Invasion in Meningiomas-Sex-Associated Differences are not Related to Estrogen- and Progesterone Receptor Expression. (2017) (4)
Fluorescence real-time kinetics of protoporphyrin IX after 5-ALA administration in low-grade glioma. (2021) (4)
Letter: Parasagittal/Falcine Tumor Location Strongly Predicts Human Telomerase Reverse Transcriptase Promoter Mutations in High-Grade Meningiomas. (2019) (4)
Multiprofessional management of giant cell tumors in the cervical spine: a systematic review. (2021) (4)
Occurrence of Fibrotic Tumor Vessels in Grade I Meningiomas Is Strongly Associated with Vessel Density, Expression of VEGF, PlGF, IGFBP-3 and Tumor Recurrence (2020) (4)
Full-endoscopic cervical arcocristectomy for the treatment of spinal stenosis: results of a cadaver study (2012) (4)
Surgical Treatment of Lumbosacral Pseudarthrosis and Spondyloptosis in a Patient with Neurofibromatosis Type 1 and a Large Lumbar Anterior Meningocele. Case Report and Review of the Literature (2014) (4)
[Modification of the retrolabyrinthine approach with hearing preservation in CPA tumors]. (2010) (4)
Repetitive percutaneous radiofrequency thermocoagulation for persistent idiopathic facial pain and central neuropathic pain attributed to multiple sclerosis—a retrospective monocentric analysis (2020) (4)
Efficacy of decitabine in malignant meningioma cells: relation to promoter demethylation of distinct tumor suppressor and oncogenes and independence from TERT. (2020) (4)
Impact of Adjuvant Radiotherapy in Patients with Central Neurocytoma: A Multicentric International Analysis (2021) (4)
Fluorescence-Guided Resection of Malignant Gliomas (2017) (4)
Lentiviral vector-mediated transduction of adult neural stem/progenitor cells isolated from the temporal tissues of epileptic patients (2020) (4)
Delineating Normal from Diseased Brain by Aminolevulinic Acid-Induced Fluorescence (2013) (3)
Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma (2022) (3)
A Tale of Two Cities: Residents’ Operative Experience in the United Kingdom and Germany During the Coronavirus Disease 2019 Pandemic (2021) (3)
Light can treat inoperable brain tumours (2019) (3)
The difficulty of predicting clinical outcome after intended submaximal resection of large vestibular Schwannomas (2018) (3)
Resection of glioblastoma [4] (multiple letters) (2002) (3)
Testing the applicability and performance of Auto ML for potential applications in diagnostic neuroradiology (2022) (3)
Predicting postoperative seizure development in meningiomas – Analyses of clinical, histological and radiological risk factors (2020) (3)
Mechanisms and Control of Blood-Brain Potassium Transport (1995) (3)
Toxicity Reduction after Craniospinal Irradiation via Helical Tomotherapy in Patients with Medulloblastoma: A Unicentric Retrospective Analysis (2021) (3)
Histopathological analysis of intracerebral hemorrhage: implications for clinical management (2012) (3)
Effect of Postoperative Radiotherapy for Brain Metastases: An Analysis (2019) (3)
Assessing preoperative risk of STR in skull meningiomas using MR radiomics and machine learning (2022) (3)
Electrical impedance, rCBF, survival and histology in Mongolian gerbils with forebrain ischaemia. (1990) (3)
[Significance of emissary veins in surgical treatment of temporal paragangliomas]. (2009) (3)
Perspectives in central nervous system malignancies. (2006) (2)
The use of radiosensitizing agents in the therapy of glioblastoma multiforme—a comprehensive review (2022) (2)
Management of spinal dumbbell tumors via a minimally-invasive posterolateral approach and carbon fiber reinforced PEEK instrumentation: technical note and surgical case series. (2021) (2)
Andexanet-Alfa-Associated Heparin Resistance in the Context of Hemorrhagic Stroke (2022) (2)
Postischemic Hyperperfusion and Outcome: An Experimental Study (1992) (2)
Protoporphyrin IX for photodynamic therapy of brain tumours (2010) (2)
Comparison of FET-PET and 5-ALA fluorescence in gliomas (2010) (2)
PET in the diagnosis and management of patients with brain metastasis: current role and future perspectives. (2011) (2)
Interstitial photodynamic therapy (iPDT) of brain tumours (Conference Presentation) (2019) (2)
Illumination in Spinal Surgery Depending on Different Approaches and Light Sources. (2017) (2)
Evaluation of 311 contemporary cases of stereotactic biopsies in patients with neoplastic and non-neoplastic lesions—diagnostic yield and management of non-diagnostic cases (2020) (2)
Fluorescence guided resection for malignant glioma using 5-aminolevulinic acid (2006) (2)
Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society (2017) (2)
Determinants of Outcome from Cerebral Ischemia in Mongolian Gerbils (1990) (2)
First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed MGMT promoter methylated IDH wildtype glioblastoma (2022) (2)
Influence of meteorological conditions on the incidence of chronic subdural hematoma, subarachnoid and intracerebral hemorrhage - the "bleeding weather hypothesis". (2020) (2)
Access to Meckel’s cave for biopsies of indeterminate lesions: a systematic review (2020) (2)
Double dose of 5-aminolevulinic acid and its effect on protoporphyrin IX accumulation in low-grade glioma. (2022) (2)
Intra-operative tissue diagnosis: isn’t it time for some reporting guidelines? (2016) (2)
Image-Guided Brain Surgery. (2020) (2)
MEDICAL RADIATION THERAPIES (2013) (2)
Feasibility, Safety and Effects of a One-Week, Ski-Based Exercise Intervention in Brain Tumor Patients and Their Relatives: A Pilot Study (2020) (2)
AT-50ALA-BASED PHOTODYNAMIC THERAPY IN RECURRENT MALIGNANT GLIOMA - A PILOT STUDY. (2014) (2)
Neurosurgery in Contemporary Medical Dramas: How Grey's Anatomy & Co. May Affect Perception of Neurosurgery in the Media (2020) (2)
A Data-Driven Approach to Predicting 5-Aminolevulinic Acid–Induced Fluorescence and World Health Organization Grade in Newly Diagnosed Diffuse Gliomas (2022) (1)
Correction to: The Simpson grading: defining the optimal threshold for gross total resection in meningioma surgery (2021) (1)
Intraoperative myelography of traumatic spine injury in patients with ankylosing spondylitis. Technical note (2016) (1)
Resection of glioblastoma. (2002) (1)
Fluorescence Guided Brain Tumor Surgery: Case Report (2015) (1)
Photodynamic E¤ects in Perifocal, Oedematous Brain Tissue (2002) (1)
Pseudoprogression prediction in high grade primary CNS tumors by use of radiomics (2022) (1)
The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, 18 F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor Molecular Factors RESEARCH HUMAN — CLINICAL STUDIES (1)
Vascular anomalies in patients with growth hormone-secreting pituitary adenomas: illustrative case report and systematic review of the literature (2022) (1)
DDEL-09. FRACTIONATED INTRACAVITARY RADIOIMMUNOTHERAPY WITH LU-177 LABELED 6A10 FAB FRAGMENTS IN PATIENTS WITH GLIOBLASTOMA (2022) (1)
QLIF-19. INITIAL PSYCHO-ONCOLOGICAL COUNSELLING IN NEURO-ONCOLOGY - ANALYSIS OF TOPICS AND NEEDS OF BRAIN TUMOUR PATIENTS (2017) (1)
Minimally Invasive Facetectomy and Fusion for Resection of Extensive Dumbbell Tumors in the Lumbar Spine (2022) (1)
Comment on: Intra-operative localisation of spinal level using pre-operative CT-guided placement of a flexible hook-wire marker (2012) (1)
Pedicle Subtraction Osteotomy for Deformity Correction in the Upper Cervical Spine: A Technical Note (2021) (1)
The NXDC-MEN-301 Study on 5-ALA for Meningiomas Surgery: An Innovative Study Design for the Assessing the Benefit of Intra-Operative Fluorescence Imaging (2022) (1)
[Interdisciplinary neuro-oncology: part 1: diagnostics and operative therapy of primary brain tumors]. (2014) (1)
5 ALA-PDT in neurosurgery (2017) (1)
Can Currently Suggested Quality Indicators Be Transferred to Meningioma Surgery?—A Single-Center Pilot Study (2022) (1)
Comment on Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540 (2021) (1)
Applicability of contemporary quality indicators in vestibular surgery—do they accurately measure tumor inherent postoperative complications of vestibular schwannomas? (2021) (1)
ARTERIOVENOUS TRANSIT TIME AS A MEASURE FOR MICROVASCULAR PERFUSION IN CEREBRAL ISCHEMIA AND REPERFUSION (2007) (1)
A video processing pipeline for intraoperative analysis of cerebral blood flow (2020) (1)
Letter to the Editor: "Surgery for Recurrent Meningiomas: The Minor Prognostic Role of the Extent of Resection". (2021) (1)
P16.11 Complete resection is not associated with improved survival in MGMT non-methylated glioblastoma. Results from the GLARIUS trial. (2017) (1)
The applicability of established clinical and histopathological risk factors for tumor recurrence during long-term postoperative care in meningioma patients (2021) (1)
Conventional and advanced imaging throughout the cycle of care of gliomas (2021) (1)
Protoporphyrin IX Analysis from Blood and Serum in the Context of Neurosurgery of Glioblastoma (2020) (1)
Combined Fluorescence-Guided Resection and Intracavitary Thermotherapy with Superparamagnetic Iron-Oxide Nanoparticles for Recurrent High-Grade Glioma: Case Series with Emphasis on Complication Management (2022) (1)
Surgical Management of Glial Cancers (2013) (1)
Radiomics for pseudoprogression prediction in high grade gliomas: added value of MR contrast agent (2022) (1)
Risk factors for preoperative seizures in intracranial meningiomas. (2020) (1)
QL-13QUALITY OF LIFE AND COGNITIVE FUNCTIONING IN THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS (2014) (0)
Hyperprolactinemia in Young Females with Questionable Lesion in Sellar Imaging: Indication for Surgery? (2014) (0)
Risk factors associated with vasospasm after non-traumatic subarachnoid hemorrhage: a retrospective analysis of 456 patients. (2022) (0)
Rapid bacterial identification from formalin‐fixed paraffin‐embedded neuropathology specimens using 16S rDNA nanopore sequencing (2022) (0)
P88 How long do SSEP need to be averaged intraoperatively? (2020) (0)
Wound Management and Wound Infections in Neurosurgery (2018) (0)
CD34 microvascularity in low-grade glioma: correlation with 5-aminolevulinic acid fluorescence and patient prognosis in a multicenter study at three specialized centers. (2022) (0)
Heterotopic Neuroglial Tissue in Sphenoid Ridge. (2019) (0)
Lack of MGMT promoter hypermethylation in hemangiopericytomas of the central nervous system (2012) (0)
O-25-371 Incidence of intraocular hemorrhage (Terson's syndrome) in patients with acutely increased intracranial pressure (1997) (0)
P16.22 Awake-Awake-Awake with dexmedetomidine compared to asleep-awake-asleep craniotomies in glioma surgery - an analysis from 180 glioma patients (2017) (0)
[Local therapy of primary brain tumors]. (2010) (0)
DEPENDENCE OF SUBARACHNOID HEMORRHAGE ON CLIMATE CONDITIONS: A SYSTEMATIC METEOROLOGICAL ANALYSIS FROM THE DÜSSELDORF METROPOLITAN AREA (2008) (0)
P89 Evoking the interpeak-latency intraoperatively (2020) (0)
SURG-08. 5-Aminolevulinic acid (5-ALA)-guided resection of pediatric brain tumors (2022) (0)
Postoperative Myoclonus After Epilepsy Surgery: A Case Report (2016) (0)
Expression and role of VEGF receptors in pituitary adenomas (2003) (0)
Abstracts DGNC (2017) (0)
Central Nervous System Injury: Prospective system analysis of the pre- and early clinical management in severe head injury (1998) (0)
Awake Neurosurgery: Treatment of Three Patients Suffering from Intractable Epilepsy Due to Brain Tumor in Iran (2014) (0)
Duration of Trigeminal Neuralgia Is the Risk Factor for Failure of Microvascular Decompression (2019) (0)
135 Real-World Data of Microvascular Decompression in Trigeminal Neuralgia: Analysis of 26 Tertiary Care Centers of the European Continent (2023) (0)
P11.15.B First multicentric real-life experience with the combination of lomustine and temozolomide in newly diagnosedMGMT promoter methylatedIDH wildtype glioblastoma (2022) (0)
Intraoperative demarcation of tumor borders by 5-ALA-induced photoporphyrin IX fluorescence for the resection of malignant glioma (1998) (0)
Correction to: Evaluation of 311 contemporary cases of stereotactic biopsies in patients with neoplastic and non-neoplastic lesions—diagnostic yield and management of non-diagnostic cases (2021) (0)
The Role of Prolonged Bed Rest in Postoperative Cerebrospinal Fluid Leakage After Surgery of Intradural Pathology-A Retrospective Cohort Study. (2023) (0)
Commentary: Perilesional Resection of Glioblastoma is Independently Associated With Improved Outcomes. (2020) (0)
Response to Drs. Bauman et al.: pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis (IJROBP 1997;45[4]:923-929, 1999) (2000) (0)
ME-19ANALYSIS OF TREG RECRUITMENT AND FOXP3 EXPRESSION IN GLIOMAS REGARDING THE INTRAOPERATIVE FLUORESCENCE OF 5-ALA (2014) (0)
HGG-19. 5-AMINOLEVULINIC ACID (5-ALA)-GUIDED RESECTION OF PEDIATRIC BRAIN TUMORS (2021) (0)
Fluorescence-guided resections of malignant gliomas using 5-ALA (2010) (0)
A cohort analysis of 'truly' incidental low-grade gliomas. (2021) (0)
Der ELS-Tumor (2009) (0)
Expression of decitabine-targeted oncogenes in meningiomas in vivo (2022) (0)
P08.12.B Conceptual development of an intensive supervised exercise program for brain tumor patients: summary of clinical experience (2022) (0)
Iatrogenic lumbosacral infiltration with petroleum (hydrodesulfurized heavy) with secondary intrathecal distribution—a case report (2023) (0)
[Neurointensive care medicine-from where, where to?] (2018) (0)
HOUT-34. ADVERSE EVENTS IN BRAIN TUMOR SURGERY: INCIDENCE, TYPE AND IMPACT ON CURRENT QUALITY METRICS (2018) (0)
A magnetic resonance imaging based radiomics model to predict mitosis cycles in intracranial meningioma (2023) (0)
SURG-12. “NANOPASTE” THERAPY AS POTENTIAL TREATMENT OPTION FOR RECURRENT GLIOBLASTOMA (2019) (0)
Predicting Meningioma Resection Status: Use of Deep Learning. (2022) (0)
Is there a functional role of bacterial endotoxin receptor (Tlr4) in pituitary tumor progression (2003) (0)
Optimizing 5-ALA induced fluorescence visualization: Comment regarding a recent article on fluorescence-based real-time kinetics PPIX measurements article Neurosurgery®. (2019) (0)
SURG-10. SPECTROSCOPIC MEASUREMENT OF 5-ALA-INDUCED INTRACELLULAR PROTOPORPHYRIN IX IN PEDIATRIC BRAIN TUMORS (2020) (0)
Contents Vol. 53, 2014 (2014) (0)
Giant Cell Tumor of the Second Cervical Vertebra: Case Report and Review of Literature (2016) (0)
Comment to the article: Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma. (2011) (0)
P14.67 Somatostatin receptor targeted radioligand therapyin head and neck paraganglioma (2019) (0)
P18.01.A The applicability of established clinical and histopathological risk factors for tumor recurrence during long-term perioperative care in meningioma patients (2022) (0)
Postoperative surveillance in cranial and spinal tumor neurosurgery: when is this warranted? (2022) (0)
Challenges in, and recommendations for, hyperspectral imaging in ex vivo malignant glioma biopsy measurements (2023) (0)
5-ALA assisted PDT of recurrent tumors in the bladder and brain: state of the art and future aspects (2004) (0)
Quantitative Analysis of the Ablation Effects of Holmium:YAG and Neodymium:YAG Laser in Human Spinal Disc Tissue (2001) (0)
Protoporphyrin IX in serum of glioblastoma patients after 5-ALA administration – a potential biomarker? (2022) (0)
Intra-operative Brain Tumor Imaging (2016) (0)
Advanced Imaging Modalities and Treatment of Gliomas: Neurosurgery (2014) (0)
514 A Data-driven Approach to Predicting 5-ALA-Induced Fluorescence and WHO Grade in Newly Diagnosed Diffuse Gliomas (2022) (0)
Thank you list 2015 (2016) (0)
Light can treat inoperable brain tumours (2019) (0)
SURG-24. QUANTITATIVE ANALYSIS OF TUMOR CELL DENSITY AND PROTOPORPHYRIN IX FLOURESCENCE IN GLIOMA PATIENTS USING PAIRED STIMULATED RAMAN HISTOLOGY AND TWO-PHOTON EXCITATION FLUORESCENCE MICROSCOPY (2022) (0)
Cervical body composition on radiotherapy planning computed tomography scans predicts overall survival in glioblastoma patients. (2023) (0)
Blood-Brain Barrier Taurine Transport and Brain Volume Regulation (1996) (0)
[Interdisciplinary neuro-oncology: part 2: systemic therapy of primary brain tumors]. (2014) (0)
Potential Mechanisms Underlying Protection Against Cerebral Ischemia by Spontaneous Locomotion in Mongolian Gerbils (1991) (0)
Fluorescence-Guided Resections: A Binary Approach to Surgery (2020) (0)
Management of spinal dumbbell tumors via a minimally-invasive posterolateral approach and carbon fiber reinforced PEEK instrumentation: technical note and surgical case series (2021) (0)
s facetectomy required for the resection of dumbbell tumors in the lumbar spine? (2022) (0)
[How useful are microsurgical operations in the treatment concept for glioblastoma multiforme]. (2004) (0)
DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups (2022) (0)
Case Report Supratentorial meningeal melanocytoma mimicking a convexity meningioma (2006) (0)
Rare cause of oculomotor palsy (2013) (0)
O6.04GRANULOCYTIC MYELOID-DERIVED CELLS OBTAINED FROM BLOOD MAINLY SUPPRESS T-CELL PROLIFERATION IN PATIENTS WITH GLIOBLASTOMA (2014) (0)
SURG-32. COMBINED INTRACAVITARY THERMOTHERAPY WITH IRON-OXIDE NANOPARTICLES AND RADIOTHERAPY AS A PROMISING TREATMENT MODALITY IN RECURRENT GBM (2017) (0)
O13: Human Neural Stem/Progenitor Cells Derived from Epileptic Human Brain in A Self-Assembling Peptide Nanoscaffold Attenuates Neuroinlammation in Traumatic Brain Injury in Rats (2018) (0)
Human Neural Stem/Progenitor Cells Derived From Epileptic Human Brain in a Self-Assembling Peptide Nanoscaffold Improve Traumatic Brain Injury in Rats (2018) (0)
Polyetheretherketone cages patients with spinal metastases: impact on postoperative radiation therapy (2017) (0)
Prospective, multicentric cohort study of surgery and radiotherapy with concomitant and adjuvant chemotherapy (temozolomide; TMZ) for patients with newly diagnosed and glioblastoma multiforme. (2010) (0)
P-3-285 Nitric oxide induced peroxidative damage in chronic cerebral vasospasm following experimental subarachnoid hemorrhage (1997) (0)
AT-54THERMOTHERAPY WITH COATED IRON OXIDE NANOPARTICLES ± RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN RECURRENT GLIOBLASTOMA: AN OPEN-LABEL RANDOMIZED CONTROLLED STUDY (2014) (0)
Correction to: Predicting the risk of postoperative recurrence and high-grade histology in patients with intracranial meningiomas using routine preoperative MRI (2021) (0)
Protoporphyrin IX (PpIX) Fluorescence during Meningioma Surgery: Correlations with Histological Findings and Expression of Heme Pathway Molecules (2023) (0)
Surface Electrodes for Detection of Eye Movements during Skull Base Surgery—A Novel Monitoring Device (2005) (0)
Symptomatic Oculomotor Nerve Cyst in a 3-Year-Old Child: Case Report With Emphasis on Surgical Management (2021) (0)
Presurgical Multimodal Imaging in Patients with Cerebral Tumors (2004) (0)
P09.05 177Lu-DOTATATE therapy in progressive meningioma (2019) (0)
Prognosis and histology of sporadic synchronous and metachronous meningiomas and comparative analyses with singular lesions (2023) (0)
Introduction. Operative imaging and visualization: cutting edge techniques and future directions. (2021) (0)
Layer V and Layer II/III Mouse Cortical Neurons Calcium Concentration During CSD and OGD in Changes in Membrane Potential and the Intracellular (2015) (0)
Augmented 5-aminolevulinic acid derived photodynamic therapy (2022) (0)
Further Interdisciplinary Considerations. (2021) (0)
QOLP-20. QUALITY OF LIFE IN THE PHASE III CeTeG/NOA-09 TRIAL RANDOMIZING CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA (2018) (0)
Clinical experiences with fluorescence guided resection of malignant glioma (2000) (0)
The in vitro anti-cancer synergy of neurokinin-1 receptor antagonist, aprepitant, and 5-aminolevulinic acid in glioblastoma. (2023) (0)
Complex Spinal Dorso-Ventral Stabilization in the Elderly – Is Age a Limiting Factor? Retrospective Case Series of 53 patients (2020) (0)
Cranial Nerve Monitoring and Intraoperative Cranial Computer Tomography for Safe Resection of Intra- and Periorbital Tumors (2014) (0)
5-ALA fluorescence in indeterminate grade gliomas (2022) (0)
O24: Human Neural Stem/Progenitor Cells Derived from Epileptic Human Brain in a Self-Assembling Peptide Nanoscaffold Improve Traumatic Brain Injury in Rats (2018) (0)
Classical and disease-specific quality indicators in glioma surgery-Development of a quality checklist to improve treatment quality in glioma patients. (2021) (0)
OBSERVATION CD 4 T Cells Predominate in Cerebrospinal Fluid and Leptomeningeal and Parenchymal Infiltrates in Cerebral Amyloid – Related Angiitis (2012) (0)
Thank you list 2017 (2018) (0)
SURG-08. AWAKE-AWAKE-AWAKE CRANIOTOMIES IN GLIOMA SURGERY (2016) (0)
How Should We Treat Meningeal Melanocytoma? A Retrospective Analysis of Potential Treatment Strategies (2022) (0)
NIMG-32. POSTPROGRESSION SURVIVAL AND MRI FEATURES AT PROGRESSION IN MGMT-METHYLATED GLIOBLASTOMA FOLLOWING TEMOZOLOMIDE (TMZ) OR CCNU/TMZ THERAPY - AN ANALYSIS OF THE CETEG/NOA-09-TRIAL (2022) (0)
Fluorescence-Guided Resection of Spinal Metastases of Malignant Glioma: Report of 2 Cases (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Walter Stummer?

Walter Stummer is affiliated with the following schools:

Heinrich Heine University Düsseldorf
University of Michigan
Stanford University
University of Münster
University of Vienna